Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp reports results for the quarter ended in December - Earnings Summary

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 35
cents​​ per share for the quarter ended in December. The mean
expectation of six analysts for the quarter was for a loss of 36
cents per share.
    * Revenue rose 39.5% to $13.71 million from a year ago; 
analysts
expected $14.24 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 35
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulmonx Corp shares had fallen by 18.1% this quarter.
    * The company reported a quarterly loss of $13.01 million.
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$36.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 24 at 05:36 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Pulmonx

See all news